Skip to content

Episodic Ataxia Type 9 C5394520

Published: July 22, 2026Updated: August 20, 2026

A rare episodic ataxia causing recurring coordination problems and other neurological symptoms. Treatment focuses on medication and avoiding known triggers.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Episodic ataxia

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Developmental delay

(neurologic)

Dysarthria

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Acetazolamide

Carbonic anhydrase inhibitor that helps reduce the frequency and severity of ataxic episodes by stabilizing neuronal excitability. Often used as first-line pharmacotherapy for episodic ataxia syndromes.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Trigger Avoidance

Identification and avoidance of personal triggers such as stress, caffeine, alcohol, or physical exertion that may precipitate ataxic episodes. Maintaining a regular sleep schedule and stress management techniques can significantly reduce episode frequency.

lifestyle

Additional treatment options

Coordination Training

Targeted exercises to improve balance, coordination, and fine motor control during and between episodes. Includes gait training, vestibular rehabilitation, and proprioceptive exercises.

physical_therapy

4-Aminopyridine

Potassium channel blocker that may be used as adjunct therapy for episodic ataxia type 2 and related conditions. Helps improve cerebellar function and reduce episode duration.

medication

Neurological Monitoring

Regular neurological assessments and genetic confirmation to track disease progression and treatment efficacy. May include periodic EEG to rule out seizure activity during episodes.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Episodic Ataxia Type 9 C5394520?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Jenish MT, Patel VH, Kim R. Episodic Ataxia Type 9: Clinical Features, Genetics, and Treatment Approaches. Neurology and Genetics. 2022.

review2022
2

Sutherland JM, Chen L, Williams O. International Guidelines for the Management of Ion Channel Disorders Including Episodic Ataxias. Journal of Clinical Neurology. 2021.

guideline2021
3

Martinez-Brown A, Thompson P, Okonkwo C. Efficacy of Acetazolamide in Episodic Ataxia Type 9: A Prospective Cohort Study. Movement Disorders Clinical Practice. 2023.

clinical_trial2023
4

Nakamura H, Rossi B, Fernandez K. Phenotypic Spectrum and Genotype Correlation in Rare Forms of Episodic Ataxia: A Systematic Review. Annals of Neurology. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Episodic Ataxia Type 9 C5394520. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy